Hugel (XKRX:145020) Construction In Progress : ₩55,552 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Hugel Construction In Progress?

Hugel's quarterly construction in progress declined from Sep. 2023 (₩63,337 Mil) to Dec. 2023 (₩55,968 Mil) and declined from Dec. 2023 (₩55,968 Mil) to Mar. 2024 (₩55,552 Mil).

Hugel's annual construction in progress increased from Dec. 2021 (₩22,094 Mil) to Dec. 2022 (₩49,696 Mil) and increased from Dec. 2022 (₩49,696 Mil) to Dec. 2023 (₩55,968 Mil).

Hugel Construction In Progress Historical Data

The historical data trend for Hugel's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hugel Construction In Progress Chart

Hugel Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

3,664.75

10,676.49

22,094.27

49,695.67

55,968.20

Hugel Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															53,668.58	56,933.21	63,337.32	55,968.20	55,551.93

Hugel Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Hugel (XKRX:145020) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hugel Inc (XKRX:145020) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

61-20, Sinbuk-ro, Sinbuk-eup, Chuncheon, Gangwon, KOR, 24206

Website

http://www.hugel.co.kr

Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing of biopharmaceuticals. The company's primary products are Botulinum toxin, Hyaluronic acid filler, and Cosmetics. It develops and promotes its products under the brand name of Wellage. The firm has manufacturing facilities in Shinbuk and Geodu.

Hugel (XKRX:145020) Headlines

No Headlines